Form 4: Thermo Fisher Scientific Director Acquires Phantom Stock Units Under Deferred Compensation Plan

Karen S. Lynch, a Director at Thermo Fisher Scientific Inc., acquired 76.54 phantom stock units as part of the company's Deferred Compensation Plan for Directors.

Summary

• Karen S. Lynch, a Director of Thermo Fisher Scientific Inc. (TMO), reported an acquisition of phantom stock units.
• The transaction occurred on June 28, 2025, and involved the acquisition of 76.54 phantom stock units.
• These units were credited to the reporting person's account at a price of $408.28 per unit.
• The acquisition was made pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan").
• Under the Plan, directors' retainers are deferred quarterly as Common Stock units based on the closing price of the stock at quarter end.
• Each phantom stock unit is convertible into Common Stock on a 1-for-1 basis.
• The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.
• Following this transaction, Karen S. Lynch beneficially owns 104.23 phantom stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine compensation event, which is expected, but it also signifies continued alignment of a director's interests with the company's performance through equity-based compensation.

Positives

• The acquisition of phantom stock units aligns the director's financial interests with those of the shareholders, as the value of these units is tied to the company's stock performance.
• The transaction is part of a structured Deferred Compensation Plan, indicating a routine and established method of director compensation.

Future Outlook

The filing does not provide forward-looking statements or guidance beyond the terms of the deferred compensation plan, which specifies that shares are distributable upon cessation of director service or a change of control.

Industry Context

This Form 4 filing details a routine insider transaction related to director compensation, which is a standard practice across various industries to align management and director interests with shareholders. It does not provide broader industry trends or competitive analysis.

Related Party Transactions

• The acquisition of phantom stock units by a director from the company under a deferred compensation plan constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The transaction aligns the director's interests with shareholders by tying a portion of their compensation to the company's stock performance.

Next Steps

• The phantom stock units will be distributed as common stock upon the cessation of director service for any reason or in the event of a change of control.

Key Dates

Keywords

Thermo Fisher Scientific, TMO, Insider Transaction, Form 4, Director Compensation, Phantom Stock Units, Deferred Compensation Plan